Q. David Yang has more than 20 years of research and management experience in the biopharmaceutical industry, including R&D, technology licensing, business development, and marketing in the United States, Singapore, and China. In 2007, David established MicroConstants China Inc. together with Gilbert Lam, President and Founder of MicroConstants Inc. As the CEO and CSO of MicroConstants China, David is responsible for overseeing the daily operations of MicroConstants’ laboratory in Beijing.
Prior to co-founding MicroConstants China, David Yang served as a Consulting Director for ST Microelectronics, one of the top five semiconductor companies in the world. Before joining ST Microelectronics, he was the General Manager for Biotech Investment at CIDC Group of Singapore. David has also held Senior Scientist positions at Collateral Therapeutics Inc. and Immusol Inc. in San Diego, California. David earned his bachelor’s degree in Biology from Fudan University in Shanghai, China, and his Ph.D. in Molecular Biology and Biochemistry from The University of Toledo Medical Center in Toledo, Ohio.